Werewolf Therapeutics, Inc. (HOWL) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 9 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for HOWL is $1.00, representing a +9.0% upside from the current price of $0.9175. Price targets range from a low of $1.00 to a high of $1.00.
